Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-01-24 @ 9:29 PM
Study NCT ID:
NCT02284035
Status:
COMPLETED
Last Update Posted:
2025-07-20
First Post:
2014-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine
Sponsor:
Juan A. Arnaiz
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-28
First Submit QC Date:
None
Study First Post Date:
2014-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-10
Results First Submit QC Date:
None
Results First Post Date:
2025-07-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-18
Last Update Post Date:
2025-07-20
Last Update Post Date Type:
ACTUAL